Regulatory Excellence AuST’s ISO 9001 and ISO 13485 certifications, along with deep experience navigating US and European regulatory pathways, position them as a turnkey development and manufacturing partner. This can support joint device development for CE marking and FDA clearance, helping clients shorten time-to-market and reduce regulatory risk.

End-to-End Capabilities With a fully resourced product development lab and pilot facility in Mountain View and volume manufacturing in Salt Lake City, AuST can shepherd products from concept to commercialization. This enables rapid design iterations, integrated clinical feedback, and seamless scale-up under a single partner.

Minimally Invasive Focus Specializing in minimally invasive devices creates a clear value proposition for OEMs and healthcare providers seeking compact, lower-risk solutions. AuST can accelerate next-generation MIS platforms by applying novel technologies to improve performance and manufacturability, reducing development risk for customers.

Strategic Footprint A two-site footprint on the West Coast and in Utah provides proximity to key US markets and a resilient supply chain. This can support local partnerships with hospitals and startups, faster prototyping cycles, and near-shoring options to optimize lead times for regulatory-driven programs.

Growth Readiness With mid-sized scale and growing revenue, AuST is well-positioned for longer-term partnerships, co-development, or licensing of novel device technologies. Their emphasis on rapid iteration, clinical feedback, and quality systems makes them an attractive partner for programs aiming to compress development timelines and secure manufacturability.